Got ME? Just get out and exercise, say scientists

Health Editor,Jeremy Laurance
Friday 18 February 2011 01:00
Comments

The UK's largest study of treatments for chronic fatigue syndrome has provided the first definitive evidence of what helps those who suffer from the disabling condition that affects 250,000 people in the UK.

The best therapies are those which help patients test the limits of their capacity, such as by gradually increasing the amount of exercise they take, the research shows. Therapy aimed at helping patients live within the limits of their capacity, by balancing rest and activity, is much less effective.

But patients' support groups angrily rejected the findings yesterday, saying they were "surprised and disappointed" by the "simplistic" results.

The attempt to settle the argument over the most effective treatment for chronic fatigue syndrome (CFS) – also called Myalgic Encephalomyelitis (ME) – was never going to be easy. It is marked by poor memory and concentration, disturbed sleep, aches and pains and disabling fatigue. It can last for years and controversy has raged for decades over the best treatments.

Now researchers from London and Edinburgh who monitored 640 severely affected adults for a year have concluded that cognitive behaviour therapy (CBT), in which patients are helped to think about and test how they can do more, and graded exercise therapy (GET), in which they are helped gradually to overcome the limits imposed by the illness, are the most effective treatments. In contrast, helping sufferers live within their limits, called Adaptive Pacing Therapy (APT), was much less helpful.

Overall, 60 per cent of patients who received CBT or GET made progress and 30 per cent recovered sufficiently to resume normal lives. Among those who received APT, half as many (15 per cent) resumed normal lives. Fewer than one in ten patients left untreated recover, the researchers said.

Michael Sharpe, professor of psychological medicine at the University of Edinburgh, and co-author of the report, said: "This is a useful effect for a substantial proportion of those affected, but it is not a solution to the illness."

The findings, published in The Lancet, were hailed by experts in chronic fatigue as "very significant." Derrick Wade, professor of neurological enablement at the Oxford Centre for Enablement said: "This means we can allocate resources to treatments that will benefit patients and stop allocating resources to treatments that will not."

However, Sir Peter Spencer, chief executive of Action for ME, said its own survey showed 82 per cent of respondents found pacing therapy helpful and a third said graded exercise made them worse. The ME Association said the findings were based on an outmoded model of the illness. "Deconditioning due to fear of activity is not the cause of the debilitating fatigue," it said.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in